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and the effects of putative viral oncogenes in 
vivo. Jon was successful in the laboratory and 
lucky outside the laboratory. During his fel-
lowship, Jon met Betsy Falloon, a wonderful 
woman who became his soulmate, his wife, 
and the mother of their three lovely children 
(Nora, Hannah, and Max).
After his NIH fellowship, Jon joined the 
Laboratory of Virology at the American Red 
Cross Holland Laboratories in suburban 
Washington, DC, where he established an 
independent, RO1-funded research program. 
Although several of the transgenic mice that 
Jon generated early in his career had skin 
phenotypes, his relationship to investigative 
dermatology and cutaneous biology became 
more formal only when he began to collabo-
rate with Stephen Katz, then Chief of the NCI’s 
Dermatology Branch. With Jon’s help, Steve 
and Alexander Enk quantified small amounts of 
cytokine messenger RNAs that were produced 
in inflamed mouse skin, providing important 
insights into the roles of Langerhans cells and 
keratinocytes in the initiation of contact hyper-
sensitivity via production of inflammatory 
mediators. This productive interaction led to 
Jon’s recruitment to the branch as a tenure-
track investigator in 1992.
Jon Vogel died on 30 October 2010 after 
battling renal cell carcinoma for less than 
a year. He was a senior investigator in the 
Dermatology Branch of the Center for Cancer 
Research, National Cancer Institute (NCI), 
National Institutes of Health (NIH), and an 
active member of the investigative dermatolo-
gy and cutaneous biology communities. Jon is 
fondly remembered by his family, colleagues, 
and friends, who miss him a great deal.
Jon was an active, adventurous child, a very 
good student, and an athlete. His passion was 
baseball, and he was both a skilled player and an 
avid fan (go, Cardinals!). Jon’s eyes were opened, 
and his life changed significantly, by his under-
graduate experience at the University of Illinois at 
Urbana–Champaign, where he became interest-
ed in laboratory research. He was elected to Phi 
Beta Kappa, authored a thesis entitled “Molecular 
Characterization of the Polymerization of Rana 
catesbeiana Hemoglobin,” and graduated with 
an honors degree in biochemistry with depart-
mental distinction.
Continuing his research career, Jon began 
his clinical training at Rush Medical College 
in Chicago, making his initial contribution to 
the biomedical literature in the form of a first-
author publication in the New England Journal 
of Medicine. After election to Alpha Omega 
Alpha, the medical school equivalent of Phi 
Beta Kappa, and graduation from Rush, Jon 
moved to Saint Louis to continue his training 
in internal medicine at Washington University/
Barnes Hospital. At Barnes, he distinguished 
himself as a highly competent, compassion-
ate physician. Like many under the tutelage of 
then Chairman of Medicine David Kipnis, Jon 
undertook a research fellowship at the NIH fol-
lowing residency training. Rather than engage 
in subspecialty training, he chose to work in a 
basic science laboratory, where he was men-
tored by two prominent scientists, Gilbert Jay 
and George Khoury. They utilized the then 
novel approach of expressing transgenes in 
mice to study regulation of gene expression 
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Although Jon was the only nondermatologist member 
of the Dermatology Branch senior staff, there was never 
any question as to whether he was an integral member 
or an equal partner. Indeed, Jon became a cornerstone of 
the branch. He appreciated the special environment that 
the NIH intramural program and the Dermatology Branch 
provides, and he took seriously the challenge that intra-
mural scientists engage in investigations that have impact 
and that effectively leverage the intramural program’s 
unique resources. Over the course of Jon’s 18-year career 
as an independent investigator at the NCI, his major focus 
migrated from studies of transgenic mice to skin gene thera-
py to isolation and characterization of normal keratinocyte 
stem cells and, ultimately, to studies of tumor-initiating cells 
(so-called “cancer stem cells”). This journey reflected Jon’s 
willingness and ability to undertake new lines of investiga-
tion, emphasizing in vivo approaches, in an effort to make 
important discoveries of direct relevance to patients.
Jon and his fellows were productive at the NIH, and he suc-
cessfully competed for tenure in 1999. In Jon’s bibliography, 
the quality and significance of his laboratory’s contributions 
stand out more than their sheer number. He was quite will-
ing to spend several years “building a better mousetrap” or 
working in a new area if that meant an important question 
could be definitively addressed. Thus, Uli Hengge and 
Jon first demonstrated that “naked DNA” was sufficient to 
achieve gene expression in mouse, pig, and human skin; Jon 
and Jeff Hildesheim studied POU transcription factors and 
keratinocyte differentiation; Jon and Patty Walker studied 
DNA-based immunomodulators in leishmaniasis; Jon and 
Wolfgang Pfutzner designed a strategy that allowed long-
term selection of genetically modified pig keratinocytes 
in vivo; Jon and Christy Tock characterized effects of solar 
radiation on the transcriptome of healthy human skin; Jon 
and Manabu Ohyama isolated and characterized stem cell–
enriched populations from the human follicular bulge; Jon 
and Atsushi Terunuma isolated and characterized human 
keratinocyte stem cells using novel proteomic approaches 
and culture methods; Jon and Jean-Phillipe Therrien atten-
uated hypertension in mice using grafted gene-modified 
human keratinocytes; and Jon and Girish Patel began the 
process of isolating and characterizing tumor-initiating cells 
from primary cutaneous human squamous cell carcino-
mas after establishing an engraftment model. At the time of 
his death, Jon and Xin Xin Quan were continuing to study 
squamous cell carcinoma, and studies of tumor-initiating 
cells in prostate cancer and kidney cancer were also ongoing 
(with Renuka Pudi Limgala and Alok Mishra, respectively). 
Over the course of his career, Jon’s research efforts were ably 
supported by two talented technicians, Ruth Ann Foster and 
Carole Yee, and Atsushi Terunuma was very much his partner 
in the laboratory over the past decade.
Jon was an excellent collaborator as well as a creative 
independent scientist. He was highly regarded by colleagues 
because of his expertise, and he was approachable, 
inquisitive, and generous with reagents, methodologies, and 
ideas. Jon’s gift of gab and delight in intense conversations 
facilitated these interactions. Because of his forthrightness 
and integrity, he was able to have close personal and profes-
sional relationships even with competitors.
Those of us who worked closely with Jon recognize that, 
in addition to being an excellent scientist and physician, 
he had many other important qualities. Born and raised in 
Illinois and the son of a successful grain merchant, in many 
ways Jon was a typical American Midwesterner. He was 
accomplished but modest, quietly confident, and incon-
spicuously generous—and he was a man of faith who did 
not advertise it. Jon was openly passionate about his family, 
and he achieved an enviable balance between his personal 
and professional lives. Despite long hours at work, it was 
not unusual for him to reveal on Monday morning the long 
list of family-related activities he had enjoyed over the 
weekend. Jon’s reward for making his family his top prior-
ity was a strong marriage and a wonderful relationship with 
each of his children.
Many of us are fortunate to work and become friends 
with a number of talented, interesting individuals over the 
course of our professional careers. If we are really lucky, 
we develop close personal relationships with a few like Jon 
Vogel. It was my privilege to know him.
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